Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 1321 AL 1335

The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0

Ritchie CW, Muniz-Terrera G, Kivipelto M, Solomon A, Tom B, Molinuevo JL.

J Prev Alzheimers Dis. 2020;7(1):8-13. doi: 10.14283/jpad.2019.46.

Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting

Jung NY, Kim ES, Kim HS, Jeon S, Lee MJ, Pak K, Lee JH, Lee YM, Lee K, Shin JH, Ko JK, Lee JM, Yoon JA, Hwang C, Choi KU, Lee EC, Seong JK, Huh GY, Kim DS, Kim EJ.

J Alzheimers Dis. 2020;74(2):473-490. doi: 10.3233/JAD-191109.

Down syndrome and dementia: advances in the field

McGlinchey E, McCallion P, McCarron M.

Curr Opin Psychiatry. 2020 May;33(3):278-283. doi: 10.1097/YCO.0000000000000589.

Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker

Lloret MA, Cervera-Ferri A, Nepomuceno M, Monllor P, Esteve D, Lloret A.

Int J Mol Sci. 2020 Feb 10;21(3):1168. doi: 10.3390/ijms21031168.

Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology

Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, Rauen K, Mantua V, Religa D, Hort J, Santuccione Chadha A, Schmidt R.

Eur J Neurol. 2020 Jun;27(6):928-943. doi: 10.1111/ene.14174. Epub 2020 Apr 3.

18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease

Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I.

J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.

Interactions between Personality, Depression, Anxiety and Cognition to Understand Early Stage of Alzheimer's Disease

Zufferey V, Gunten AV, Kherif F.

Curr Top Med Chem. 2020;20(9):782-791. doi: 10.2174/1568026620666200211110545.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology

Shen X, Ma S, Vemuri P, Simon G; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2020 Feb 19;10(1):2975. doi: 10.1038/s41598-020-59669-x.

The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum

Banning LCP, Ramakers IHGB, Köhler S, Bron EE, Verhey FRJ, de Deyn PP, Claassen JAHR, Koek HL, Middelkoop HAM, van der Flier WM, van der Lugt A, Aalten P; Alzheimer's Disease Neuroimaging Initiative; Parelsnoer Institute Neurodegenerative Diseases study group.

Am J Geriatr Psychiatry. 2020 Jul;28(7):735-744. doi: 10.1016/j.jagp.2020.01.012. Epub 2020 Feb 20.

Genetic Variants and Oxidative Stress in Alzheimer's Disease

Kowalska M, Wize K, Prendecki M, Lianeri M, Kozubski W, Dorszewska J.

Curr Alzheimer Res. 2020;17(3):208-223. doi: 10.2174/1567205017666200224121447.

CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration

Carlini V, Verduci I, Cianci F, Cannavale G, Fenoglio C, Galimberti D, Mazzanti M.

Int J Mol Sci. 2020 Feb 21;21(4):1484. doi: 10.3390/ijms21041484.

Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?

Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I.

Curr Protein Pept Sci. 2020;21(12):1184-1192. doi: 10.2174/1389203721666200226101930.

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease

Yin Q, Ji X, Lv R, Pei JJ, Du Y, Shen C, Hou X.

Clin Interv Aging. 2020 Feb 13;15:195-205. doi: 10.2147/CIA.S240400. eCollection 2020.

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM; Synaptic Health Endpoints Working Group.

Alzheimers Res Ther. 2020 Mar 2;12(1):21. doi: 10.1186/s13195-020-00588-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias